Therapeutic approaches to management of migraine attacks during coronavirus pandemic: Review of literature and results of our own evaluation of efficacy of zolmitriptan-Reference-Cited by-同舟云学术

Therapeutic approaches to management of migraine attacks during coronavirus pandemic: Review of literature and results of our own evaluation of efficacy of zolmitriptan

Published:2022-07-26 Issue:14 Volume: Page:32-40
ISSN:2078-5631
Container-title:Medical alphabet
language:
Short-container-title:Medicinskij alfavit

Author:

Korsunskaya L. L.¹^ORCID,Meshcheryakova A. V.¹^ORCID,Kot A. O.¹^ORCID,Braude I. E.¹^ORCID

Affiliation:

1. Crimean Federal University n. a. V. I. Vernadsky

Abstract

A review of the literature on the frequency, probable causes, and clinical characteristics of the headache syndrome in COVID‑19 is presented. The description of one of the most common types of headache as a neurological manifestation of a new coronavirus infection – migraine – is given. The results of our own evaluation of the high efficacy and safety of zolmitriptan for the relief of migraine attacks are presented.

Publisher

Alfmed LLC

Subject

Materials Chemistry,Economics and Econometrics,Media Technology,Forestry

Reference36 articles.

1. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016 [published correction appears in Lancet 2017 Oct 28; 390 (10106): e38] Lancet. 2017; 390: 1211–59.

2. Haghdoost F., Carcel C., Chandrasekhar D., Rodgers A., Delcourt C. J Neurol. 2021 Dec; 268 (12): 4429–4435. DOI: 10.1007/s00415–021–10590-x.

3. Al-Hashel J.Y., Ismail I. I. Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study. J Headache Pain 21, 115 (2020). https://doi.org/10.1186/s10194-020-01183-6

4. Jin X., Lian J. S., Hu J. H., Gao J., Zheng L., Zhang Y. M., Hao S. R., Jia H. Y., Cai H., Zhang X. L., Yu G. D., Xu K. J., Wang X. Y., Gu J. Q., Zhang S. Y., Ye C. Y., Jin C. L., Lu Y. F., Yu X., Yu X. P., Huang J. R., Xu K. L., Ni Q., Yu C. B., Zhu B., Li Y. T., Liu J., Zhao H., Zhang X., Yu L., Guo Y. Z., Su J. W., Tao J. J., Lang G. J., Wu X. X., Wu W. R., Qv T. T., Xiang D. R., Yi P., Shi D., Chen Y., Ren Y., Qiu Y. Q., Li L. J., Sheng J., Yang Y. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020; 69 (6): 1002–1009. DOI: 10.1136/gutjnl-2020–320926

5. Porta-Etessam J., Matías-Guiu J.A., GonzálezGarcía N., Gómez Iglesias P., Santos-Bueso E., Arriola-Villalobos P., García-Azorín D., Matías-Guiu J. Spectrum of headaches associated with SARS-CoV-2 infection: Study of healthcare professionals. Headache. 2020; 60 (8): 1697–1704. DOI: 10.1111/head.13902.